SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd. | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Large | 4 | Jan 12, 2023 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2030 Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location Israel Company Size Large Target Statement Teva Pharmaceutical Industries Ltd. commits to reduce absolute scope 1 and 2 GHG emissions by 46.2% by 2030 from a 2019 base year.* Teva also commits to reduce absolute scope 3 GHG emissions 25% by 2030 from a 2020 base year. *The target boundary includes biogenic land-related em… Stakeholders SVP, Global Head of Sustainability and ESG Linda Caramichael Senior Director, Global Head of Environment and Sustainability Adam Ajzensztejn Senior Director, Head of Sustainability Reporting and Engagement Eder Morales Director, Sustainable Procurement & Supplier Diversity Lead | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.